OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR applications in cancer diagnosis and treatment
Mingxia Wang, Menghui Chen, Xia Wu, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

CRISPR–Cas9 applications in T cells and adoptive T cell therapies
Xiaoying Chen, Shuhan Zhong, Yonghao Zhan, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 10

Benzenesulfonamide decorated dihydropyrimidin(thi)ones: carbonic anhydrase profiling and antiproliferative activity
Hakan Aslan, G. RENZI, Andrea Angeli, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 6, pp. 1929-1941
Open Access | Times Cited: 5

CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy
Mingming Qin, Chunhao Deng, Liewei Wen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

CRISPR-Cas in Parasites: Advances and Challenges in the Study of Neglected Tropical Diseases
Ana María Mejía‐Jaramillo, Omar Triana‐Chávez
(2025), pp. 65-83
Closed Access

Emerging technology has a brilliant future: the CRISPR-Cas system for senescence, inflammation, and cartilage repair in osteoarthritis
Shicheng Jia, Rongji Liang, Jiayou Chen, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3

Advanced strategies for CRISPR/Cas9 delivery and applications in gene editing, therapy, and cancer detection using nanoparticles and nanocarriers
Adric Ru Khiing Hii, Xiaole Qi, Zhenghong Wu
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 6, pp. 1467-1489
Closed Access | Times Cited: 2

CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer
Danielle Smith, Sapna Lunj, Antony Adamson, et al.
Nature Reviews Urology (2024)
Closed Access | Times Cited: 2

CRISPR‐Cas9 technology: As an efficient genome modification tool in the cancer diagnosis and treatment
Ghazaleh Behrouzian Fard, Mohammad Hossein Ahmadi, Mehran Gholamin, et al.
Biotechnology and Bioengineering (2023) Vol. 121, Iss. 2, pp. 472-488
Closed Access | Times Cited: 7

Nanomaterials as signal amplifiers in CRISPR/Cas biosensors: A path toward multiplex point-of-care diagnostics
Fareeha Arshad, Bong Jing Yee, Koo Pey Ting, et al.
Microchemical Journal (2024) Vol. 207, pp. 111826-111826
Closed Access | Times Cited: 1

State of the art CRISPR-based strategies for cancer diagnostics and treatment
Emma Di Carlo, Carlo Sorrentino
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1

CRISPR/Cas system and its application in the diagnosis of animal infectious diseases
Hafiz Muhammad Hamza Rasool, Qiwei Chen, Xiaowei Gong, et al.
The FASEB Journal (2024) Vol. 38, Iss. 24
Open Access | Times Cited: 1

Page 1

Scroll to top